跳至主要内容
临床试验/IRCT201012185414N1
IRCT201012185414N1已完成2 期

Comparison of Labetalol versus Hydralazin in control of Hypertension in preeclamptic patients and the out come of their pregnancy

Vice chancellor for research, Kashan University of Medical Sciences0 个研究点目标入组 190 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
190

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 45 years(—)
性别
Female

入选标准

  • Every pregnant woman by gestational age 20 to 42 weeks with a BP>160/105, singleton, estimated fetal weight < 4500 g
  • Exclusion criteria:
  • 1. History of basic chronic diseases ,including chronic HTN, hyperthyroidism, arrhythmia
  • 2. Non cephalic presentation, macrosomia, thick meconium, previous history of caesarian section or uterine rupture which abdicate the option of NVD of patients. 3. History of long infertility, stillbirth, anomalous child, every reason for high risk pregnancy.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Kashan University of Medical Sciences

相似试验